Back to 
Marex Group Ltd
Marex Group Ltd
PPCB
4 quarters
Position history for Marex Group Ltd's holdings in Propanc Biopharma, Inc.
No. Marex Group exited its PPCB (Propanc Biopharma) position in Q2 2026. Its Q1 2026 13F listed 67,724 shares worth $7,179. Marex Group first reported PPCB in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$119,729
Total Shares Change
-70,429
Quarter-by-Quarter History
Other major holders of PPCB: Virtu Financial LLC, UBS Group AG, Jane Street Group, LLC, XTX Topco Ltd, Two Sigma Investments, LP